CLBCX | MSFFX | CLBCX / MSFFX | |
Total Expense Ratio | 1.35 | 1.47 | 92% |
Annual Report Gross Expense Ratio | 1.35 | 1.47 | 92% |
Fund Existence | 24 years | 20 years | - |
Gain YTD | 10.785 | 7.357 | 147% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 258B | 7.78B | 3,318% |
Annual Yield % from dividends | 1.11 | 1.60 | 69% |
Returns for 1 year | 9.15 | -0.05 | -18,305% |
Returns for 3 years | 37.75 | 12.36 | 305% |
Returns for 5 years | 36.30 | 7.24 | 502% |
Returns for 10 years | 74.80 | 29.72 | 252% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNGLX | 70.49 | 0.55 | +0.79% |
Janus Henderson Global Life Sciences D | |||
JSVRX | 29.21 | 0.09 | +0.31% |
JPMorgan Small Cap Value R5 | |||
CICAX | 65.58 | 0.08 | +0.12% |
American Funds Invmt Co of Amer 529A | |||
SGIGX | 35.36 | N/A | N/A |
Steward Global Equity Income Fund R6 | |||
PAXGX | 17.67 | N/A | N/A |
Impax Global Opportunities Investor |